Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Mar 28;8(4):71.
doi: 10.3390/biomedicines8040071.

Current Advances in Pediatric Onset Multiple Sclerosis

Kristen S Fisher  1 , Fernando X Cuascut  2 , Victor M Rivera  2 , George J Hutton  2
Affiliations
Review

Current Advances in Pediatric Onset Multiple Sclerosis

Kristen S Fisher et al. Biomedicines. .

Abstract

Multiple sclerosis (MS) is an autoimmune inflammatory disease affecting the central nervous system leading to demyelination. MS in the pediatric population is rare, but has been shown to lead to significant disability over the duration of the disease. As we have learned more about pediatric MS, there has been a development of improved diagnostic criteria leading to earlier diagnosis, earlier initiation of disease-modifying therapies (DMT), and an increasing number of DMT used in the treatment of pediatric MS. Over time, treatment with DMT has trended towards the initiation of higher efficacy treatment at time of diagnosis to help prevent further disease progression and accrual of disability over time, and there is evidence in current literature that supports this change in treatment patterns. In this review, we discuss the current knowledge in diagnosis, treatment, and clinical outcomes in pediatric MS.

Keywords: child neurology; demyelinating disease; multiple sclerosis; neuroimmunology; pediatric multiple sclerosis; pediatric neurology.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

References

    1. Boiko A., Vorobeychik G., Paty D., Devonshire V., Sadovnick D., UBC MS Clinic Neurologists Early onset multiple sclerosis: A longitudinal study. Neurology. 2002;59:1006–1010. doi: 10.1212/WNL.59.7.1006. - DOI - PubMed
    1. Bigi S., Banwell B. Pediatric multiple sclerosis. J. Child. Neurol. 2012;27:1378–1383. doi: 10.1177/0883073812452784. - DOI - PubMed
    1. Tenembaum S. Multiple sclerosis in childhood and adolescence. J. Neurol. Sci. 2011;311:S53–S57. doi: 10.1016/S0022-510X(11)70010-7. - DOI - PubMed
    1. Gordon-Lipkin E., Banwell B. An update on multiple sclerosis in children: Diagnosis, therapies, and prospects for the future. Expert Rev. Clin. Immunol. 2017;13:975–989. doi: 10.1080/1744666X.2017.1360135. - DOI - PubMed
    1. Waldman A., Ghezzi A., Bar-Or A., Mikaeloff Y., Tardieu M., Banwell B. Multiple sclerosis in children: An update on clinical diagnosis, therapeutic strategies, and research. Lancet Neurol. 2014;13:936–948. doi: 10.1016/S1474-4422(14)70093-6. - DOI - PMC - PubMed

LinkOut - more resources